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Abstract
Background:  Recent studies have suggested that the Arg  allele of β3-adrenergic receptor
(ADRB3) gene is associated with body mass index (BMI), which is an important predictor of bone
mineral density (BMD) and fracture risk. However, whether the ADRB3 gene polymorphism is
associated with fracture risk has not been investigated. The aim of study was to examine the inter-
relationships between ADRB3 gene polymorphisms, BMI, BMD and fracture risk in elderly
Caucasians.
Methods: Genotypes of the ADRB3 gene were determined in 265 men and 446 women aged 60+
in 1989 at entry into the study, whose BMD were measured by DXA (GE Lunar, WI USA) at
baseline. During the follow-up period (between 1989 and 2004), fractures were ascertained by
reviewing radiography reports and personal interviews.
Results: The allelic frequencies of the Trp and the Arg alleles were 0.925 and 0.075 respectively,
and the relative frequencies of genotypes Trp/Trp, Trp/Arg and Arg/Arg 0.857, 0.138 and 0.006
respectively. There was no significant association between BMI and ADRB3 genotypes (p = 0.10 in
women and p = 0.68 in men). There was also no significant association between ADRB3 genotypes
and lumbar spine or femoral neck BMD in either men and women. Furthermore, there were no
significant association between ADRB3 genotypes and fracture risk in both women and men, either
before or after adjusting for and, BMD and BMI.
Conclusion: The present data suggested that in Caucasian population the contribution of ADRB3
genotypes to the prediction of BMI, BMD and fracture risk is limited.
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Background
Osteoporosis and obesity are two common disorders that
affect a large number of elderly in the general population
[1-3]. Approximately 30% of women and 12% of men are
affected by osteoporosis or low bone mass at some point
during life [4]. Moreover, about 31% of elderly men and
35% of elderly women are classified as having obesity in
the US [5]. Several lines of epidemiologic evidence suggest
that the two disorders may be inversely associated, with
obese individuals having higher bone mineral density
(BMD) and reduced risk of fracture than non-obese indi-
viduals [6-11]. Indeed, it has been well-known that
between 23% and 47% variance of BMD in the general
population can be "explained" by the variation in body
mass index (BMI) [12,13], making BMI one of the most
robust and consistent predictors of BMD [14]. Both body
weight (or BMI) and BMD are partly genetically deter-
mined. Twin studies have suggested that genetic factors
may account for up to 80% of the BMD variance [15-17].
Likewise, between 43 to 70% of BMI variance is attributa-
ble to genetic factors [18,19]. Under the hypothesis of
shared genetic effects, a gene that is associated with BMI
may also protect against osteoporosis.
The variation in BMD is mainly attributable to genetic fac-
tors [16,17,20] and the liability to osteoporotic fracture is
also partly determined by genetic factor [21-23]. Experi-
mental evidence suggested that β3-adrenergic stimulation
can induce expression of osteoclast differentiation factor
in osteoblast cells, leading to a stimulation of osteoclas-
togenesis [24]. Moreover, the activation of β3-adrenergic
receptors on two osteoblast-like cells can cause bone
resorption in intact mouse calvariae [25]. In epidemiolog-
ical studies, the β3-adrenergic receptor (ADRB3) poly-
morphisms have been found to be associated with BMI
[26] and BMD [27]. However, such associations, while
largely found in the Japanese population, have not been
well studied in Caucasian populations. Moreover, the
association between ADRB3 polymorphisms and fracture
risk, the ultimate outcome of osteoporosis has not been
reported. The present study was aimed at examining the
inter-relationships between ADRB3 gene polymorphisms,
body mass index, bone mineral density and fracture risk
in a well-defined sample of elderly Caucasians.
Methods
Study design and setting
The present study was part of the Dubbo Osteoporosis
Epidemiology Study (DOES), of which the details of study
design and protocols have been described previously [28-
30]. Briefly, DOES is a community-based, epidemiologi-
cal study, where participants were recruited from the
Dubbo city, a semi-urban city 400 km northwest of Syd-
ney, Australia, with a population of approximately 32 000
people, 98.6% Caucasian, of whom 1 581 men and 2 095
women were aged 60 years or above in 1989. Dubbo's rel-
ative isolation in terms of medical care allows virtually
complete ascertainment of all fractures. From 1993, blood
samples were collected from individuals who volunteer to
donate at initial visits or follow-up visits. Our present
study reports data on a random sample of 446 women
and 265 men aged 60 years or above in 1989, who had
consented to donate blood for DNA analysis.
Measurements
After obtaining written informed consent, participants
were interviewed by a trained research nurse at initial and
subsequent visits at approximately 2-year intervals. A
structured questionnaire was used to collect data includ-
ing age, anthropometric variables, life style and clinical
data [31]. Bone mineral density (g/cm2) was measured at
the lumbar spine and femoral neck by dual-energy X-ray
absorptiometry (DXA) using a Lunar DPX-L densitometer
(GE Lunar, WI. USA). The measurement was performed at
the same visit or within one month of the blood sample
collection in 99% of cases. In the cases in which the blood
was taken at a time other than the scheduled visit, the
BMD used was that closest to the time of blood collection.
Ascertainment of fracture
The incidence of fracture was ascertained during the study
period (1989–2004) by radiologist's report and con-
firmed by personal interview. Only low trauma fractures
were included (i.e. a fall from the standing height or less).
Fractures due to motor vehicle accidents or pathological
conditions were excluded. Fractures were categorised into
4 groups: hip, symptomatic vertebral, Colles' and other
fractures.
Genotyping
Genomic DNA was extracted from peripheral blood leu-
kocytes. The ADRB3 polymorphism was determined by
polymerase chain reaction (PCR) performed with 20 ng of
genomic DNA with upstream primer 5' CCA GTG GGC
TGC CGA GGG 3' and downstream primer 5' GCC AGT
GGC GCC CAA CGG 3' [32]. The amplification products
were digested with the restriction enzyme BstOI
(Promega, Madison, WI, USA) and genotyped as Trp
homozygotes (Trp/Trp), heterozygotes (Trp/Arg), or Arg
homozygotes (Arg/Arg). This Trp64Arg polymorphism has
been commonly used in genetic epidemiological studies.
Statistical analysis
Alleles were counted and the genotype frequencies of the
polymorphism was checked for Hardy-Weinberg equilib-
rium (HWE) by the likelihood Chi-square statistic [33].
The baseline characteristics of the subjects in the fracture
group and the non-fracture group were compared using
descriptive statistical tests with appropriate techniques
(e.g. Student's t-test for normally distributed variables,BMC Medical Genetics 2006, 7:57 http://www.biomedcentral.com/1471-2350/7/57
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such as BMI and BMD) and Chi-square (for categorical
data), depends on the distribution of the variables. The
association between each polymorphism and BMD or
BMI was analyzed by the analysis of covariance
(ANCOVA) model taking into account the effects of
potential covariates such as age, weight and life-style fac-
tors.
In order to quantify the risk of sustaining a fracture in rela-
tion to ADRB3 genotypes, subjects were grouped into
those with Arg allele and those without Arg allele. The
association was analyzed by the logistic regression model
taking into account the effects of potential confounders.
In order to determine the association between BMI and
ADRB3 polymorphisms, a Bayesian approach was used
[34,35]. In the Bayesian analysis, the currently observed
data are combined with known data to derive a "posterior
distribution" with credible interval. In the present study, a
prior mean difference (M0) in BMI between subjects with
and without Arg allele was obtained from a meta-analysis
[26] with a 95% confidence interval (95%CI) being (L0,
U0), from which the standard deviation (SD0) for the
prior distribution was calculated as follow: SD0 = (U0- L0)/
3.92, assuming the difference follows the normal distribu-
tion. In order to construct a posterior distribution with
mean (Mp) and standard deviation (SDp), the prior distri-
bution was combined with the present study's data, which
has a mean of Md and standard deviation of SDd. The pos-
terior mean and SD are: Mp =(SDp)2 [(M0/SD0
2)+(Md/SDd
2)] and SDp = 1/ . Thus, the poste-
rior mean is a weighted average of two estimates (prior
mean and the present study's mean) with the weight being
the inverse variances. The analysis was conducted via the
SAS system [36].
Results
Characteristics of study subjects
In total, 446 women and 265 men who had been fol-
lowed-up for the median of 13.2 years (interquartile
range, IQR: 10.4–14.1) and 12.9 years (IQR: 9.0–14.0) for
women and men, respectively.
The frequencies of the Trp/Trp, Trp/Arg and Arg/Arg geno-
types were 385 (86.3%), 58 (13.0%) and 3 (0.7%) respec-
tively for women, and 224 (84.5), 40 (15.1%) and 1
(0.4%) respectively for men. In both sexes, the allelic fre-
quencies of Trp allele and Arg allele were 0.925 and 0.075
respectively. Because the frequency of Arg allele was low in
the population, individuals with Trp/Arg and Arg/Arg gen-
otypes were considered as one group. The overall geno-
type distribution in the study subjects was in Hardy-
Weinberg equilibrium (χ2  = 0.007, p = 0.98).
Clinical characteristics of subjects were stratified by the
presence or absence of Arg allele (Table 1). The presence
of  Arg  allele in women is associated with a 0.25 SD
increase in body weight, but this difference was not statis-
tically significant (p = 0.08). In both women and men,
there were no statistically significant differences between
Arg allele carriers and non-carriers in terms of anthropo-
metric characteristics and lifestyle factors.
ADRB3 genotypes and BMI
In the present study, there was no significant association
between ADRB3 genotypes and BMI. The overall mean
difference in BMI for Arg carriers versus non-carriers was
0.54 kg/m2 (95% CI: -0.35, 1.44; P = 0.23), or 0.13 SD. In
a previous meta-analysis [26], Arg carriers had higher BMI
than non-Arg carriers by 0.30 (95% CI, 0.13–0.47) kg/m2
as indicated in the prior distribution (Figure 1). After
updating the previous data with the present study's data,
the posterior distribution showed that BMI in the Arg
allele carriers are, on average, 0.31 kg/m2 (95% CI, 0.14–
0.48) higher than non-Arg carriers.
ADRB3 genotypes and BMD
In multiple regression analysis of BMD measurements at
both lumbar spine and femoral neck (Table 2), there were
no significant associations between ADRB3 and BMD at
both LS and FN sites. However, in both women and men,
age and smoking history were negatively associated with
femoral neck BMD, and BMI was positively associated
with lumbar spine and femoral neck BMD. Although
increased physical activity was not associated with BMD
measured at femoral neck, it was positively associated
with lumbar spine BMD. Collectively these factors (age,
BMI, smoking history, calcium intake, physical activity
and ADRB3 genotypes) explained about 30% and 12% of
variances in femoral neck BMD in women and men
respectively.
ADRB3 genotypes and fracture risk
During the follow up period, 173 women and 49 men had
sustained at least one osteoporotic fracture. In women,
the most common fracture site was distal radius (Colles'
fracture) with an incidence rate of 24% of all the cases, fol-
lowed by vertebral (23%) and hip (14%). In men, the
most common fracture site was vertebrae (41%), followed
by hip (16%) and ribs (14%). For both women and men,
fracture individuals were older, weighed less, and had
lower BMD at both femoral neck and lumbar spine com-
pared to their non-fracture counterparts (Table 3). How-
ever, there was no significant difference between the
fracture group and non-fracture group in terms of calcium
intake, physical activity and smoking history.
(/ ) (/ ) 11 0
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The distribution of ADRB3 genotypes in fracture and non-
fracture subjects is shown in Table 4. Women with the
Arg/Arg and Trp/Arg genotypes had lower incident rate of
any fracture than those with the Trp/Trp genotype, but the
difference was not statistically significant (32.8% vs.
39.7%, p = 0.30). This non-significant association was
observed for all specific fracture sites. However, in men,
individuals with the Arg/Arg and Trp/Arg genotypes had
higher incident rate of any fracture than those with the
Trp/Trp genotype (22.0% vs. 17.9%); the difference was
also not statistically significant (p = 0.53). After adjusting
for age, BMI and/or BMD, the associations between the
ADRB3 polymorphism and fracture risk in women and
men were not statistically significant (Table 5). There were
no interaction effects between ADRB3 genotypes and age
on fracture risk (data not shown).
Discussion
Obesity is associated with increased BMD and reduced
fracture risk [11,37]. Studies on polymorphisms of the
ADRB3 gene and their association with BMD have been
reported in the Japanese population [27,38], but not in
Caucasians. The present data further suggested that there
was no significant association between ADRB3 genotypes
and fracture risk in a Caucasian population.
The ADRB3 genotypes have largely been investigated for
association with BMI in the Japanese population, from
whom a significant association has been reported. The
association was characterised by individuals with the Arg
allele having higher BMI than individuals without the Arg
allele. In this study, individuals with the Arg allele also
had higher BMI than individuals without the Arg allele,
but the difference did not reach statistical significance.
Nevertheless, by using the Bayesian approach (i.e., updat-
ing the current data with previous data) it was found that
there was a 99% probability that BMI among those with
the Arg allele was higher than those without the Arg allele.
The frequency of the Arg allele in the present study was
similar to that reported for the Australian population [39]
and other Caucasian populations [40,41], but lower than
that of Asian populations [27,42-44]. To our knowledge,
the present study is the first to investigate the association
between ADRB3 genotypes and BMD and fracture risk in
Caucasian population.
The present results suggest there was no statistically signif-
icant association between ADRB3 genotypes and BMD.
This is consistent with previous findings in Japanese
women [27,38] (Table 6). It has been suggested that the
association between ADRB3 and BMD are more likely to
be found in obese individuals than in non-obese individ-
uals. However, in the present study, the non-significant
association between ADRB3 and BMD was observed in
both obese and non-obese individuals (data not shown).
Table 1: Baseline characteristics of subjects stratified by ADRB3 genotype
Trp/Trp Trp/Arg + Arg/Arg Standardized difference P value
Women (N) 385 61
Age (y) 71 ± 8 71 ± 6 0.00 0.47
Weight (kg) 64 ± 12 67 ± 13 0.25 0.08
Height (cm) 160 ± 6 160 ± 6 0.00 0.90
BMI (kg/m2) 25 ± 5 26 ± 5 0.20 0.10
Ca intake (mg/day) 644 ± 372 650 ± 355 0.02 0.90
Physical activity (METs) 80 ± 30 82 ± 23 0.07 0.54
Femoral neck BMD (g/cm2) 0.76 ± 0.13 0.79 ± 0.13 0.23 0.24
Lumbar spine BMD (g/cm2) 1.00 ± 0.18 1.04 ± 0.21 0.22 0.11
Age of menopause (y) 47 ± 7 46 ± 7 -0.14 0.52
Current/ex smoker a,b 106 (27.5) 22 (36.1) 1.87
Men (N) 224 41
Age (y) 70 ± 6 68 ± 5 -0.34 0.12
Weight (kg) 78 ± 12 77 ± 13 -0.08 0.46
Height (cm) 174 ± 6 173 ± 8 -0.16 0.77
BMI (kg/m2) 26 ± 3 26 ± 4 0.00 0.68
Ca intake (mg/day) 657 ± 367 732 ± 317 0.21 0.23
Physical activity (METs) 76 ± 49 72 ± 48 -0.08 0.69
Femoral neck BMD (g/cm2) 0.92 ± 0.15 0.93 ± 0.15 0.07 0.63
Lumbar spine BMD (g/cm2) 1.26 ± 0.21 1.24 ± 0.24 -0.09 0.59
Current/ex smoker a,b 122 (54.5) 25 (61.0) 0.59
Values are mean ± SD, otherwise specified; P values were calculated using unpaired t-test, otherwise specified. BMI, body mass index; Ca, calcium; 
METs, metabolic equivalents.
a N(%); bChi-square test.BMC Medical Genetics 2006, 7:57 http://www.biomedcentral.com/1471-2350/7/57
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In this current study, no significant association was
observed in either sex. However, while women with the
Arg allele appeared to have lower risk of fracture, men
with the Arg allele had increased risk of fracture. The rea-
son for this opposite trend was not apparent; however,
stochastic fluctuation can be a contributory factor.
BMD is largely determined by genetic factors [45], and as
BMI is a strong predictor of BMD [14], we thus hypothe-
sized that ADRB3, being a candidate gene for BMI, would
have pleiotropic effect on both BMD and BMI. However,
the present results did not support the hypothesis, and the
effect of ADRB3 seemed to be BMI specific, and the effect
of ADRB3 on BMI showed a 0.31 kg/m2  difference
between genotypes.
The present study was based on a relatively large sample
size which has been followed up for a reasonably long
period of time (up to 15 years), which allows more precise
delineation of effect than smaller studies. Moreover, sub-
jects in this study are of Caucasian background, and the
present results are likely to be valid in similar populations
of elderly Caucasians. However, a potential limitation is
that with the low prevalence of the Arg  allele in the
ADRB3 gene there are small numbers of subjects with the
Arg/Arg genotype. Since fracture is a relatively rare event,
the lack of fracture cases in individuals with Arg allele
could limit the power of the study.
Furthermore, this study examined only one polymor-
phism which may not adequately capture the polymor-
phic variation within the gene, and hence limited the
chance of finding an underlying association. There is also
a lack of association studies investigating the relationship
between ADRB3 genotypes and BMD, and no studies have
investigated the association between ADRB3 genotypes
and fracture risk, therefore no prior information could be
drawn to reinforce our findings via the Bayesian
approach.
Conclusion
In summary, the present data suggested that in elderly
men and women, there is a weak positive association
between Arg allele of the ADRB3 gene and BMI. However,
no significant associations were observed between ADRB3
polymorphisms and BMD or fracture risk, and it seems
unlikely that ADRB3 has a significant predictive value for
osteoporotic fracture risk.
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Posterior distribution of mean difference in BMI (kg/m2)  between Arg carriers and non-Arg carriers Figure 1
Posterior distribution of mean difference in BMI (kg/m2) 
between Arg carriers and non-Arg carriers.
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Table 2: ADRB3 genotype and BMD: Standardized regression coefficient from the multiple regression analyses
LSBMD FNBMD
Coefficient P value Coefficient P value
Women
Age -0.040 0.380 -0.344 <0.01
BMI 0.366 <0.01 0.382 <0.01
Smoking -0.041 0.37 -0.087 0.03
Calcium intake -0.018 0.69 0.050 0.23
Physical activity 0.140 <0.01 0.035 0.40
ADRB3a 0.044 0.33 0.046 0.26
R2 0.162 0.302
Men
Age -0.018 0.78 -0.187 <0.01
BMI 0.231 <0.01 0.240 <0.01
Smoking -0.104 0.09 -0.149 <0.01
Calcium intake 0.091 0.14 0.048 0.01
Physical activity 0.124 0.05 0.036 0.43
ADRB3a 0.001 0.99 0.003 0.60
R2 0.074 0.120
LSBMD, lumbar spine bone mineral density; FNBMD, femoral neck bone mineral density.
R2: coefficient of determination; proportion of variance of BMD (LSBMD or FNBMD) accounted for by all the factors in the model. aNon-Arg allele 
carrier and Arg allele carrier.
Table 3: Baseline characteristics of subjects with and without fracture
Any fracture Non-fracture Mean difference (95% CI) SDa P value
Women
Number of subjects 173 273
Age (y) 72 ± 8 70 ± 7 1.86 (0.46, 3.226) 0.27 <0.01
Weight (kg) 63 ± 12 66 ± 12 -2.76 (-5.14, -0.38) -0.25 0.03
Height (cm) 159 ± 7 160 ± 6 -0.89 (-2.06, 0.27) -0.16 0.13
BMI (kg/m2) 25 ± 4 26 ± 5 -0.88 (-1.76, 0) -0.22 0.05
Ca intake (mg/day) 640 ± 379 648 ± 364 -7.70 (-78.93, 63.52) -0.02 0.83
Physical activity (METs) 83 ± 32 79 ± 27 3.67 (-1.99, 9.32) 0.14 0.20
Femoral neck BMD (g/cm2) 0.72 ± 0.12 0.80 ± 0.13 -0.07 (-0.10, -0.05) -0.63 <0.01
Lumbar spine BMD (g/cm2) 0.95 ± 0.17 1.04 ± 0.19 -0.09 (-0.12, -0.05) -0.49 <0.01
Age of menopause (y) 46 ± 8 47 ± 7 -1.46 (-2.86, -0.06) -0.14 0.04
Current/ex smoker b,c 46 (26.6) 82 (30.0) 0.43
Men
Number of subjects 49 216
Age (y) 73 ± 6 69 ± 6 3.54 (1.73, 5.36) 0.67 <0.01
Weight (kg) 75 ± 11 79 ± 12 -4.05 (-7.81, -0.29) -0.34 0.03
Height (cm) 171 ± 7 174 ± 6 -2.75 (-4.82, -0.69) -0.48 0.01
BMI (kg/m2) 25 ± 3 26 ± 4 -0.54 (-1.64, 0.55) -0.26 0.33
Ca intake (mg/day) 693 ± 475 663 ± 330 29.77 (-83.66, 143.19) 0.08 0.61
Physical activity (METs) 84 ± 53 73 ± 47 11.19 (-4.59, 26.98) 0.23 0.16
Femoral neck BMD (g/cm2) 0.85 ± 0.13 0.94 ± 0.15 -0.09 (-0.14, -0.05) -0.61 <0.01
Lumbar spine BMD (g/cm2) 1.14 ± 0.20 1.28 ± 0.21 -0.14 (-0.21, -0.07) -0.67 <0.01
Current/ex smoker b, c 33 (67.3) 114 (52.8) 0.06
Values are mean ± SD, otherwise specified; P values are calculated using unpaired t-test, otherwise specified. BMI, body mass index; Ca, calcium; 
METs, metabolic equivalents;
a Standardized difference; bChi-square test; cN(%).BMC Medical Genetics 2006, 7:57 http://www.biomedcentral.com/1471-2350/7/57
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Table 5: Relationship between β3-Adrenergic Receptor genotypes and fracture risk
Any fracture Hip fracture Vertebral fracture Wrist/forearmb
Women
ADRB3 unadjusteda 0.74 (0.42, 1.31) 0.66 (0.23,1.92) 0.56 (0.21, 1.46) 0.55 (0.21, 1.43)
Adjusted for age (1) 0.72 (0.40, 1.28) 0.66 (0.22,1.96) 0.55 (0.21, 1.43) 0.54 (0.21, 1.42)
Adjusted for FNBMD (2) 0.84 (0.46, 1.55) 0.83 (0.25, 2.77) 0.62 (0.24, 1.64) 0.61 (0.23, 1.61)
Adjusted for BMI (3) 0.76 (0.42, 1.37) 0.82 (0.27, 2.44) 0.60 (0.23, 1.56) 0.57 (0.22, 1.50)
Adjusted for (1) and (2) 0.84 (0.45, 1.55) 0.78 (0.23, 2.61) 0.60 (0.23, 1.58) 0.61 (0.23, 1.60)
Adjusted for (1) and (3) 0.74 (0.41, 1.33) 0.70 (0.23, 2.16) 0.57 (0.22, 1.51) 0.56 (0.22, 1.48)
Adjusted for (1) and (2) 
and (3)
0.83 (0.45, 1.53) 0.75 (0.22, 2.56) 0.60 (0.23, 1.59) 0.61 (0.23, 1.60)
Men
ADRB3 unadjusteda 1.29 (0.57, 2.92) 1.39 (0.28, 6.76) 1.69 (0.59, 4.88) 1.84 0.19, 18.18)
Adjusted for age (1) 1.57 (0.68, 3.65) 2.87 (0.50, 16.39) 2.03 (0.69, 6.02) -
Adjusted for FNBMD (2) 1.25 (0.52, 3.04) 1.47 (0.29, 7.46) 1.88 (0.62, 5.71) -
Adjusted for BMI (3) 1.28 (0.56, 2.89) 1.34 (0.27, 6.58) 1.66 (0.57, 4.78) -
Adjusted for (1) and (2) 1.47 (0.60, 3.62) 3.03 (0.52, 17.54) 2.15 (0.69, 6.67) -
Adjusted for (1) and (3) 1.57 (0.67, 3.65) 2.85 (0.50, 16.39) 2.02 (0.68, 6.02) -
Adjusted for (1) and (2) 
and (3)
1.46 (0.59, 3.62) 2.88 (0.48, 7.24) 2.15 (0.69, 6.67) -
Values are Odds ratio and 95% CI;
aArg-allele carriers were considered the risk factor in the model and Trp/Trp genotype was the reference group.
badjusted OR was not calculated for wrist/forearm fracture in men due to small number of fracture.
Table 4: Frequency of fracture types stratified by β3-Adrenergic Receptor genotype
Genotype P valuea
Trp/Trp Arg/Arg+
Trp/Arg
Women (N) 385 61
Non-fracture 232 (60.3) 41 (67.2)
Any fracture 153 (39.7) 20 (32.8) 0.30
Hip fracture 37 (13.8) 4 (8.9) 0.66b
Vertebral fracture 53 (18.6) 5 (10.9) 0.23
Wrist/forearm 54 (18.9) 5 (10.9) 0.21
Men (N) 224 41
Non-fracture 184 (82.1) 32 (78.1)
Any fracture 40 (17.9) 9 (22.0) 0.53
Hip fracture 8 (4.2) 2 (5.9) 0.66b
Vertebral fracture 17 (8.5) 5 (13.5) 0.33
Wrist/forearm 3 (1.6) 1 (3.0) 0.49b
aChi-square test, otherwise specified; bFisher's exact testBMC Medical Genetics 2006, 7:57 http://www.biomedcentral.com/1471-2350/7/57
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